Where to from here, page-53

First 53 Last

Share
Profile

Follow
tobyjack

9,236 Posts.

2

11/05/17

14:43

Post #: 24628356
Share

Originally posted by madamswer ↑

@hottuna,

You are to be commended for your nuggety ferreting around and looking for dangerous flaws in business models, and for then alerting people to them.

To the extent that there is excessive spruiking and over-promoting of stocks without any well-founded countervailing arguments supported by fact-based research, you are providing a valuable public service for free.

The part of your post that sticks in my craw is that the stockbroker tells its clients to buy the share with a Target Price of $3.38 (accurate to 2 decimal places, no less, connoting some sort of analytical precision, presumably).

But when the broker's advice is proven to be inordinately inept, it then blames to company for it, citing "apparent lack of transparency" as the reason why the broking analyst got it so ludicrously wrong.

Surely the analysis that resulted in the target price that was generated should have factored in the "lack of transparency"?

And then, after this unbridled professional incompetence, the broker simply washes his hands of the entire sorry saga, dismissively brushes it all under the carpet and moves onto generate more "Target Prices" on the next big thing which gets peddled to poor, unwitting investors.

It's a heinous profession.

Imagine if a doctor made such bad mistakes in their diagnosis of a health condition, or a lawyer dispensed such bad legal advice.

And then, when the adverse consequences of their malpractice were brought to their respective attention, they simply said, "Well, hard luck. I'm simply not dealing with that situation any longer; I'm moving onto the next patient/case."

Like I said, stockbroking is a contemptible profession.

Expand

Totally agree with your assessment.

Three broker reports are on QIN's website and are noted as being "from independent investment advisors"

1 Canaccord - dated 1/5/17 - target $3.38
2. Moelis - dated 27/2/17 - target $3.18
3. Argonaut - dated 20/4/17 - target $1.50

What makes this saga enven more sorry is that Canaccord Genuity (Australia) Limited and Moelis Australia Advisory Pty Ltd acted as joint lead managers and joint book-runners to the placement in the May 2016 $60 mil cap raise @ $1.55/share and the $5 mil SPP.

Canaccord now wipe their hands - that's after receiving how much in commission?

The trouble with brokers is none of them do any forensic analysis that anyone can rely on.

QIN Price at posting: 43.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

TAT

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

ASX

ASX explains: How 'futures' are predicted

RDN

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

GMD

Genesis set for higher gold production in FY25 and earlier mill start